Patients with untreated chronic hepatitis B who had metabolic comorbidities were at a higher risk for advanced liver fibrosis and were less likely to see improvement with antiviral therapy than those ...

HCV infection is the underlying cause for chronic Hepatitis C (CHC), liver cirrhosis, and liver cancer or hepatocellular carcinoma (HCC). In 2019, over 2,90,000 people died of HCV-related diseases.

Hepatitis B (HBV) is a viral infection that affects the liver by causing inflammation. This can lead to permanent scarring, what medical professionals call liver fibrosis or cirrhosis. Most hepatitis ...

Among patients with noncirrhotic chronic hepatitis B, concurrent MASLD may not affect fibrosis progression. Concurrent metabolic dysfunction-associated steatotic liver disease (MASLD) is not ...

Early screening for liver disease in type 2 diabetes is crucial for improving patient outcomes and preventing severe ...

The schematic diagram maps the involvement of specific DUBs throughout the progression of liver disease, including MASLD, liver fibrosis, hepatitis, and HCC. Arrows directed at HCC denote DUBs that ...

For many years, it was believed that when an individual develops liver scarring, it can not be reversed. Today, we know that ...

Women who have two or more cardiometabolic risk factors were linked to a higher likelihood of significant liver fibrosis ...

World Liver Day is observed on April 19 to raise awareness about liver diseases and the importance of liver health. Learn key facts about fatty liver, hepatitis, alcohol-related liver disease, ...